Combined Targeting of Estrogen Receptor Alpha and Exportin 1 in Metastatic Breast Cancers

The majority of breast cancer specific deaths in women with estrogen receptor positive (ER(+)) tumors occur due to metastases that are resistant to therapy. There is a critical need for novel therapeutic approaches to achieve tumor regression and/or maintain therapy responsiveness in metastatic ER(+...

Descripción completa

Detalles Bibliográficos
Autores principales: Cotul, Eylem Kulkoyluoglu, Zuo, Qianying, Santaliz-Casiano, Ashlie, Imir, Ozan Berk, Mogol, Ayca Nazli, Tunc, Elif, Duong, Kevin, Lee, Jenna Kathryn, Ramesh, Rithva, Odukoya, Elijah, Kesavadas, Mrinali P., Ziogaite, Monika, Smith, Brandi Patrice, Mao, Chengjian, Shapiro, David J., Park, Ben Ho, Katzenellenbogen, Benita S., Daly, Drew, Aranda, Evelyn, O’Neill, John D., Walker, Christopher, Landesman, Yosef, Madak-Erdogan, Zeynep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563274/
https://www.ncbi.nlm.nih.gov/pubmed/32847042
http://dx.doi.org/10.3390/cancers12092397

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563274/
https://www.ncbi.nlm.nih.gov/pubmed/32847042
http://dx.doi.org/10.3390/cancers12092397

Ejemplares similares